NORAD and gastric cancer: In the case of NORAD, its interaction with miR-214 could finally provoke a significant increase of p-AKT and p-mTOR levels in the cells to trigger a greater proliferation and other tumorigenic characteristics in both in vivo and in vitro GC models, as well as a reduction of apoptosis in GC cells [66].